Harvard Apparatus Regenerative Technology HRGN Estimates

OTC HRGN
$2.19 -0.01 (-0.45%)
At close: Oct 2, 2026 · 4:00 PM EDT
Analyst Estimates

Harvard Apparatus Regenerative Technology, Inc. Annual Revenue Estimates

Periods 5
Next Period 2017
Consensus 106,075.58

Analysts expect Harvard Apparatus Regenerative Technology, Inc. to report revenue of 106,075.58 for 2017, against a range of 96,090.26 to 116,060.90.

Metric 20172018201920202021
Reported (Actual) --
High Estimate 116,060.90139,820.14
Low Estimate 96,090.26127,996.82
Consensus Estimate 106,075.58133,908.48
Analyst Estimates

Harvard Apparatus Regenerative Technology, Inc. Annual Earnings Per Share (EPS) Estimates

Periods 5
Next Period 2020
Consensus -3.92

Analysts expect Harvard Apparatus Regenerative Technology, Inc. to report earnings per share of -3.92 for 2020, against a range of -4.26 to -3.58. The most recent reported year, 2019, came in at -1.21, a 83.8% beat against the -7.46 consensus.

Metric 20172018201920202021
Reported (Actual) -6.63-1.69-1.21--
High Estimate -7.45-7.07-6.96-3.585.69
Low Estimate -8.99-7.53-7.96-4.265.35
Consensus Estimate -8.22-7.30-7.46-3.925.52

Harvard Apparatus Regenerative Technology, Inc. Estimates API

Pull Wall Street consensus for Harvard Apparatus Regenerative Technology, Inc. (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/estimates?ticker=HRGN&mode=revenue&api_key=YOUR_API_KEY